volume 30 issue 1 pages 121-122

Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial

Rikiya Taoka 1
Hideo Fukuhara 2
Makito Miyake 3
Keita Kobayashi 4
Atsushi Ikeda 5
Kent Kanao 6
Yoshinobu Komai 7
Ryo Fujiwara 7
Yusuke Sato 8
Mikio Sugimoto 1
Toyonori Tsuzuki 9
Kiyohide Fujimoto 3
Keiji Inoue 10
Oya Mototsugu 11
Publication typeJournal Article
Publication date2024-11-19
scimago Q1
wos Q2
SJR0.936
CiteScore5.2
Impact factor2.8
ISSN13419625, 14377772
Found 

Top-30

Journals

1
International Journal of Urology
1 publication, 100%
1

Publishers

1
Wiley
1 publication, 100%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1
Share
Cite this
GOST |
Cite this
GOST Copy
Taoka R. et al. Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial // International Journal of Clinical Oncology. 2024. Vol. 30. No. 1. pp. 121-122.
GOST all authors (up to 50) Copy
Taoka R., Fukuhara H., Miyake M., Kobayashi K., Ikeda A., Kanao K., Komai Y., Fujiwara R., Sato Y., Sugimoto M., Tsuzuki T., Fujimoto K., Inoue K., Mototsugu O. Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial // International Journal of Clinical Oncology. 2024. Vol. 30. No. 1. pp. 121-122.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s10147-024-02654-5
UR - https://link.springer.com/10.1007/s10147-024-02654-5
TI - Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial
T2 - International Journal of Clinical Oncology
AU - Taoka, Rikiya
AU - Fukuhara, Hideo
AU - Miyake, Makito
AU - Kobayashi, Keita
AU - Ikeda, Atsushi
AU - Kanao, Kent
AU - Komai, Yoshinobu
AU - Fujiwara, Ryo
AU - Sato, Yusuke
AU - Sugimoto, Mikio
AU - Tsuzuki, Toyonori
AU - Fujimoto, Kiyohide
AU - Inoue, Keiji
AU - Mototsugu, Oya
PY - 2024
DA - 2024/11/19
PB - Springer Nature
SP - 121-122
IS - 1
VL - 30
PMID - 39560814
SN - 1341-9625
SN - 1437-7772
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Taoka,
author = {Rikiya Taoka and Hideo Fukuhara and Makito Miyake and Keita Kobayashi and Atsushi Ikeda and Kent Kanao and Yoshinobu Komai and Ryo Fujiwara and Yusuke Sato and Mikio Sugimoto and Toyonori Tsuzuki and Kiyohide Fujimoto and Keiji Inoue and Oya Mototsugu},
title = {Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial},
journal = {International Journal of Clinical Oncology},
year = {2024},
volume = {30},
publisher = {Springer Nature},
month = {nov},
url = {https://link.springer.com/10.1007/s10147-024-02654-5},
number = {1},
pages = {121--122},
doi = {10.1007/s10147-024-02654-5}
}
MLA
Cite this
MLA Copy
Taoka, Rikiya, et al. “Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial.” International Journal of Clinical Oncology, vol. 30, no. 1, Nov. 2024, pp. 121-122. https://link.springer.com/10.1007/s10147-024-02654-5.